Want to join the conversation?
Medical products company $ENDP delivered solid revenue and adjusted EPS results in 2Q16 with revenue performance across all business units broadly in line or ahead of company expectations. The company affirms full-year 2016 revenue and adjusted EPS guidance despite some additional investments.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.